Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A’s: Abundance, Activation and Antigen-Delivery

Recent advances in cancer immunotherapy have mainly focused on re-activating T-cell responses against cancer cells. However, both priming and activation of effector T-cell responses against cancer-specific antigens require cross-talk with dendritic cells (DCs), which are responsible for the capturin...

Descripción completa

Detalles Bibliográficos
Autores principales: Murgaski, Aleksandar, Bardet, Pauline M. R., Arnouk, Sana M., Clappaert, Emile J., Laoui, Damya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562396/
https://www.ncbi.nlm.nih.gov/pubmed/31091774
http://dx.doi.org/10.3390/cancers11050670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562396/
https://www.ncbi.nlm.nih.gov/pubmed/31091774
http://dx.doi.org/10.3390/cancers11050670

Ejemplares similares